VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 124 filers reported holding VIRIDIAN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,021,965 | -35.4% | 262,188 | +0.2% | 0.00% | -100.0% |
Q2 2023 | $6,227,256 | -15.1% | 261,759 | -9.2% | 0.00% | – |
Q1 2023 | $7,334,252 | +20858.0% | 288,296 | +23964.8% | 0.00% | – |
Q4 2022 | $34,995 | +288.8% | 1,198 | +170.4% | 0.00% | – |
Q3 2022 | $9,000 | +800.0% | 443 | +542.0% | 0.00% | – |
Q2 2022 | $1,000 | – | 69 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 2,699,865 | $68,684,566 | 13.41% |
COMMODORE CAPITAL LP | 2,189,659 | $55,704,925 | 8.48% |
Fairmount Funds Management LLC | 1,369,623 | $34,843,209 | 5.99% |
Paradigm Biocapital Advisors LP | 2,085,698 | $53,060,157 | 5.03% |
Octagon Capital Advisors LP | 1,185,000 | $30,146,400 | 4.34% |
Logos Global Management LP | 950,000 | $24,168,000 | 3.46% |
TCG Crossover Management, LLC | 663,610 | $16,882,238 | 3.29% |
ACUTA CAPITAL PARTNERS, LLC | 168,000 | $4,273,920 | 3.15% |
Vivo Capital, LLC | 1,678,207 | $42,693,586 | 2.96% |
TANG CAPITAL MANAGEMENT LLC | 692,925 | $17,628,012 | 2.63% |